Rupam Manna/LinkedIn
May 9, 2026, 22:18
Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on LinkedIn:
”Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery!
From definition and grading to all causes (CIT, marrow infiltration, radiation, immune-mediated, hypersplenism, DIC) – clinical manifestations – evaluation – platelet thresholds for chemo and procedures – impact on treatment outcomes.
Key sections:
- Common culprit drugs (carboplatin, gemcitabine, temozolomide, PARP inhibitors, checkpoint inhibitors & more)
- Practical platelet thresholds for chemo, central lines, LP, surgery
- Treatment ladder: Transfusions, chemo modification, TPO-RAs (romiplostim, eltrombopag, avatrombopag)
- Prophylaxis and important oncology pearls (carboplatin nadir, persistent thrombocytopenia clues)
Reduces delays, dose reductions and improves quality of life plus survival!”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026